Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Gavert

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Cancer Research|July 20, 2007
Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancerDanijela Vignjevic, Marie Schoumacher, Nancy Gavert, et al.
Cancer Research|August 19, 2007
Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasisNancy Gavert, Michal Sheffer, Shani Raveh, et al.
Journal of Personalized Medicine|June 25, 2026
Clinical Utility of an Ex Vivo Functional Test in Personalized Cancer TreatmentVered Bar, Adi Zundelevich, Nancy Gavert, et al.
Nature Communications|July 5, 2020
Predicting and affecting response to cancer therapy based on pathway-level biomarkersRotem Ben-Hamo, Adi Jacob Berger, Nancy Gavert, et al.
Cancer Biology & Therapy|March 23, 2018
Ex-vivo organ culture as potential prioritization tool for breast cancer targeted therapyAlbert Grinshpun, Nancy Gavert, Roy Zvi Granit, et al.
Nature Cancer|February 5, 2022
IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapyAdi Jacob Berger, Elinor Gigi, Lana Kupershmidt, et al.
Cell|September 30, 2022
Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactionsLian Narunsky-Haziza, Gregory D Sepich-Poore, Ilana Livyatan, et al.
Nature Cancer|February 11, 2022
Ex vivo organotypic cultures for synergistic therapy prioritization identify patient-specific responses to combined MEK and Src inhibition in colorectal cancerNancy Gavert, Yaara Zwang, Roi Weiser, et al.
Frontiers in Medicine|October 16, 2023
A clinical evaluation of an <i>ex vivo</i> organ culture system to predict patient response to cancer therapyShay Golan, Vered Bar, Seth J Salpeter, et al.
Nature Cancer|November 14, 2025
Characterization of the tumor microbiome of brain metastases and glioblastoma reveals tumor-type-specific and location-specific microbial signaturesElinor Gigi, Nancy Gavert, Lilach Raijman-Nagar, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Cancer Research|July 20, 2007
Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancerDanijela Vignjevic, Marie Schoumacher, Nancy Gavert, et al.
Cancer Research|August 19, 2007
Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasisNancy Gavert, Michal Sheffer, Shani Raveh, et al.
Journal of Personalized Medicine|June 25, 2026
Clinical Utility of an Ex Vivo Functional Test in Personalized Cancer TreatmentVered Bar, Adi Zundelevich, Nancy Gavert, et al.
Nature Communications|July 5, 2020
Predicting and affecting response to cancer therapy based on pathway-level biomarkersRotem Ben-Hamo, Adi Jacob Berger, Nancy Gavert, et al.
Cancer Biology & Therapy|March 23, 2018
Ex-vivo organ culture as potential prioritization tool for breast cancer targeted therapyAlbert Grinshpun, Nancy Gavert, Roy Zvi Granit, et al.
Nature Cancer|February 5, 2022
IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapyAdi Jacob Berger, Elinor Gigi, Lana Kupershmidt, et al.
Cell|September 30, 2022
Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactionsLian Narunsky-Haziza, Gregory D Sepich-Poore, Ilana Livyatan, et al.
Nature Cancer|February 11, 2022
Ex vivo organotypic cultures for synergistic therapy prioritization identify patient-specific responses to combined MEK and Src inhibition in colorectal cancerNancy Gavert, Yaara Zwang, Roi Weiser, et al.
Frontiers in Medicine|October 16, 2023
A clinical evaluation of an <i>ex vivo</i> organ culture system to predict patient response to cancer therapyShay Golan, Vered Bar, Seth J Salpeter, et al.
Nature Cancer|November 14, 2025
Characterization of the tumor microbiome of brain metastases and glioblastoma reveals tumor-type-specific and location-specific microbial signaturesElinor Gigi, Nancy Gavert, Lilach Raijman-Nagar, et al.
Pageof 5